Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Blane Fillingim
- Brian Post
- Lauren Heinrich
- Peeyush Nandwana
- Sudarsanam Babu
- Thomas Feldhausen
- Yousub Lee
- Brian Sanders
- Bruce Moyer
- Debjani Pal
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Jeffrey Einkauf
- Jennifer M Pyles
- Jerry Parks
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Mike Zach
- Padhraic L Mulligan
- Paul Abraham
- Ramanan Sankaran
- Sandra Davern
- Vilmos Kertesz
- Vimal Ramanuj
- Wenjun Ge
- Xiaohan Yang
- Yang Liu

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

This work seeks to alter the interface condition through thermal history modification, deposition energy density, and interface surface preparation to prevent interface cracking.

Additive manufacturing (AM) enables the incremental buildup of monolithic components with a variety of materials, and material deposition locations.

Ceramic matrix composites are used in several industries, such as aerospace, for lightweight, high quality and high strength materials. But producing them is time consuming and often low quality.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The invention provides on-line analysis of droplets for mass spectrometry.